English | 繁體

Search in the results

UM

Browse/Search Results:  1-5 of 5 Help

Selected(0)Clear Items/Page:    Sort:
Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy Journal article
Yuxin Zhao, Haiyong Wang, Chengwei He. Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy[J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147(12), 3653-3664.
Authors:  Yuxin Zhao;  Haiyong Wang;  Chengwei He
Favorite | TC[WOS]:20 TC[Scopus]:19  IF:2.7/3.1 | Submit date：2021/12/08
Non-small Cell Lung Cancer  Targeted Therapy  Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor  Drug Resistance  
Inhibition of pyruvate dehydrogenase kinase 1 enhances the anti-cancer effect of EGFR tyrosine kinase inhibitors in non-small cell lung cancer Journal article
Yang, Zheng, Zhang, Shao-Lin, Hu, Xiaohui, Tam, Kin Yip. Inhibition of pyruvate dehydrogenase kinase 1 enhances the anti-cancer effect of EGFR tyrosine kinase inhibitors in non-small cell lung cancer[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 838, 41-52.
Authors:  Yang, Zheng;  Zhang, Shao-Lin;  Hu, Xiaohui;  Tam, Kin Yip
Favorite | TC[WOS]:27 TC[Scopus]:27  IF:4.2/4.3 | Submit date：2018/10/30
Dichloroacetophenone  Epidermal Growth Factor Receptor  Tyrosine Kinase Inhibitor  Synergism  Hypoxia  Oxidative Phosphorylation  
Prognostic significance of combining VEGFA, FLT1 and KDR mRNA expression in lung cancer Journal article
Zhang S.-D., McCrudden C.M., Kwok H.F.. Prognostic significance of combining VEGFA, FLT1 and KDR mRNA expression in lung cancer[J]. Oncology Letters, 2015, 10(3), 1893-1901.
Authors:  Zhang S.-D.;  McCrudden C.M.;  Kwok H.F.
Favorite | TC[WOS]:20 TC[Scopus]:23 | Submit date：2018/12/19
Angiogenesis  Fms‑related Tyrosine Kinase 1  Kinase Insert Domain Receptor  Lung Cancer  Survival  Vascular Epidermal Growth Factor a  
Sunitinib produces neuroprotective effect via inhibiting nitric oxide overproduction Journal article
Wei Cui, Zai-Jun Zhang, Sheng-Quan Hu, Shing-Hung Mak, Da-Ping Xu, Chung-Lit Choi, Yu-Qiang Wang, Wah-Keung Tsim, Ming-Yuen Lee, Jian-Hui Rong, Yi-Fan Han. Sunitinib produces neuroprotective effect via inhibiting nitric oxide overproduction[J]. CNS Neuroscience and Therapeutics, 2014, 20(3), 244-252.
Authors:  Wei Cui;  Zai-Jun Zhang;  Sheng-Quan Hu;  Shing-Hung Mak;  Da-Ping Xu; et al.
Favorite | TC[WOS]:32 TC[Scopus]:31 | Submit date：2018/11/06
Cancer  Neuroprotection  Nitric Oxide  Nitric Oxide Synthase  Receptor Tyrosine Kinase  Sunitinib  
Chemical constituents from the heartwood of Haematoxylon campechianum as protein tyrosine kinase inhibitors Journal article
Lin L.-G., Xie H., Wang Y.-T., Ding J., Ye Y.. Chemical constituents from the heartwood of Haematoxylon campechianum as protein tyrosine kinase inhibitors[J]. Chemistry and Biodiversity, 2014, 11(5), 776.
Authors:  Lin L.-G.;  Xie H.;  Wang Y.-T.;  Ding J.;  Ye Y.
Favorite | TC[WOS]:12 TC[Scopus]:12 | Submit date：2018/10/31
Epihematoxylol b  Haematoxylon Campechianum  Hematoxylol b, 10-o-methyl-  Homoisoflavonoids  Kinase Insert Domain Receptor (Kdr)  Protein Tyrosine Kinases (Ptks)